TrademarkDir
FUSION PHARMACEUTICALS INC.
LIVE

Serial Number

90667641

Owner

Fusion Pharmaceuticals Inc.

Attorney

Jonathan M. Gelchinsky

First Use Date

Mar 27, 2023

Filing Date

Apr 23, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FUSION PHARMACEUTICALS INC. Trademark

Serial Number: 90667641 • Registration: 7122419

FUSION PHARMACEUTICALS INC. is a trademark filed by Fusion Pharmaceuticals Inc. on April 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Fusion Pharmaceuticals Inc. (4 trademarks)

Hamilton, Ontario L8P0A6 , CA

Entity Type: 03

Trademark Details

Filing Date

April 23, 2021

Registration Date

July 25, 2023

First Use Anywhere

March 27, 2023

First Use in Commerce

March 27, 2023

Published for Opposition

May 31, 2022

Goods & Services

Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 25, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 23, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 22, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 6, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 6, 2023 AITU
USE AMENDMENT FILED
May 15, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
May 15, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 2, 2023 EX1G
SOU EXTENSION 1 FILED
May 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 2, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 29, 2022 NOAM
NEW NOA TO ISSUE
Oct 17, 2022 NEWN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 28, 2022 NOAM
NOTICE OF ALLOWANCE CANCELLED
Jul 26, 2022 IUCN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 31, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2021 NWOS
NEW APPLICATION ENTERED
Apr 27, 2021 NWAP

Related Trademarks

More from this Owner

FUSION PHARMACEUTICALS INC. logo

FUSION PHARMACEUTICALS INC.

FUSION PHARMACEUTICALS INC. logo

FUSION PHARMACEUTICALS INC.

FUSION PHARMACEUTICALS INC. logo

FUSION PHARMACEUTICALS INC.

FUSION

FUSION

FUSION

FUSION

FUSION

FUSION